Q/C Technologies, Inc. (QCLS) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -14.15M USD | Operating Income (Loss) |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 1.80M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-14.15M | (m) | (m) | $1.80M | (m) | (m) |
| 2026-03-31 | $-9.23M | (m) | (m) | $2.44M | (m) | (m) |
| 2025-12-31 | $-9.85M | (m) | (m) | $3.47M | (m) | (m) |
| 2025-09-30 | $-8.32M | (m) | (m) | $3.91M | (m) | (m) |
| 2025-06-30 | $-8.36M | (m) | (m) | $4.26M | (m) | (m) |
| 2025-03-31 | $-9.86M | (m) | (m) | $3.79M | (m) | (m) |
| 2024-12-31 | $-10.17M | (m) | (m) | $3.44M | (m) | (m) |
| 2024-09-30 | $-12.89M | (m) | (m) | $5.27M | (m) | (m) |
| 2024-06-30 | $-14.91M | (m) | (m) | $6.47M | (m) | (m) |
| 2024-03-31 | $-17.32M | (m) | (m) | $8.30M | (m) | (m) |
| 2023-12-31 | $-17.12M | (m) | (m) | $7.87M | (m) | (m) |
| 2023-09-30 | $-16.02M | (m) | (m) | $7.38M | (m) | (m) |
| 2023-06-30 | $-15.89M | (m) | (m) | $7.27M | (m) | (m) |
| 2023-03-31 | $-13.75M | (m) | (m) | $7.21M | (m) | (m) |
| 2022-12-31 | $-15.28M | (m) | (m) | $9.07M | (m) | (m) |
| 2022-09-30 | $-14.51M | (m) | (m) | $7.32M | (m) | (m) |
| 2022-06-30 | $-15.21M | (m) | (m) | $8.53M | (m) | (m) |
| 2022-03-31 | $-29.84M | (m) | (m) | $8.02M | (m) | (m) |
| 2021-12-31 | $-28.81M | (m) | (m) | $6.75M | (m) | (m) |
| 2021-09-30 | $-32.86M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $-31.58M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $-10.23M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-12.29M | (m) | (m) | $7.96M | (m) | (m) |
| 2020-09-30 | $-10.31M | (m) | (m) | $6.21M | (m) | (m) |
| 2020-06-30 | $-9.39M | $862.03K | $1.18M | $4.53M | (m) | -1089.31% |
| 2020-03-31 | $-6.55M | $1.33M | $1.03M | $2.67M | (m) | -493.19% |
| 2019-12-31 | $-3.95M | $1.58M | $1.10M | $276.79K | (m) | -250.22% |
| 2019-09-30 | $-5.56M | $1.78M | $1.21M | $410.09K | (m) | -312.72% |
| 2019-06-30 | $-7.82M | $1.91M | $1.40M | $513.46K | (m) | -408.52% |
| 2019-03-31 | $-9.11M | $1.98M | $1.49M | $711.67K | (m) | -461.06% |
| 2018-12-31 | $-10.06M | $1.67M | $1.54M | $1.06M | (m) | -604.02% |
| 2018-09-30 | $-10.38M | $2.32M | (m) | $1.11M | (m) | -446.65% |
| 2018-06-30 | $-8.44M | $2.44M | (m) | $1.24M | (m) | -345.28% |
| 2018-03-31 | $-7.15M | $2.99M | (m) | $1.28M | (m) | -238.97% |
| 2017-12-31 | $-5.05M | $3.93M | (m) | $1.24M | (m) | -128.59% |
| 2017-09-30 | $-4.31M | $3.19M | (m) | $1.19M | (m) | -134.85% |
| 2017-06-30 | $-2.83M | $3.13M | (m) | $1.14M | (m) | -90.32% |
| 2017-03-31 | $-3.17M | $2.89M | (m) | $1.17M | (m) | -109.82% |
| 2016-12-31 | $-3.33M | $2.96M | (m) | $1.19M | (m) | -112.42% |
| 2016-09-30 | $-6.09M | $2.78M | (m) | $1.34M | (m) | -219.36% |
| 2016-06-30 | $-8.74M | $2.33M | (m) | $1.41M | (m) | -374.55% |
| 2016-03-31 | $-9.84M | $2.34M | (m) | $1.46M | (m) | -419.93% |
| 2015-12-31 | $-9.68M | $2.12M | (m) | $1.41M | (m) | -457.78% |
| 2015-09-30 | $-6.76M | $3.09M | (m) | $1.23M | (m) | -218.38% |
| 2015-06-30 | $-5.55M | $3.38M | (m) | $1.10M | (m) | -164.42% |
| 2015-03-31 | $-3.95M | $3.76M | (m) | $968.34K | (m) | -104.99% |
| 2014-12-31 | $-3.20M | $4.43M | (m) | $916.31K | (m) | -72.37% |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-1.81M | $3.58M | (m) | $1.01M | (m) | -50.61% |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |